4th Quarter - Report

SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.4356 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022; Matters related to Gene Therapy funding

LobbyistCovered position, as disclosed
STACEY FRISK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4356 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.